Clinical trial
Efficacy Vulvovaginitis Candida
NCT00199264 · J. Uriach and Company, Industry · Terminated
Key facts
| NCT number | NCT00199264 |
|---|---|
| Title | Efficacy Vulvovaginitis Candida |
| Official title | A Single-Blind, Randomized, Dose-Finding Study Versus Fluconazole to Assess the Efficacy and Tolerability of Five Single Doses of Albaconazole in the Treatment of Acute Non-Recurrent Candida Spp Vulvovaginitis |
| Lead sponsor | J. Uriach and Company, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Candidiasis Vulvaginitis |
| Intervention type | Drug |
| Interventions | Albaconazole oral solution |
| Enrollment | 60 |
| Start date | Jun 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 3, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: